Martin A. Mattingly - Apr 19, 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role: Director
Signature: /s/ Scott B. Brown, Attorney-in-Fact
Stock symbol: TCON
Transactions as of: Apr 19, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/21/2023, 08:44 PM
Previous filing: Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCON	Director Stock Option (Right to Buy)	Award	$0	+18K		$0.00	18K	Apr 19, 2023	Common Stock	18K	$1.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).

Content

The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).